Drug intelligence / Profile preview

aconitum coreanum extract

Development stage
Preclinical
Administration
Oral
01

Overview

*Aconitum coreanum* extract is a traditional herbal medicine derived from the dried tuberous root of the plant *Aconitum coreanum* (Lévl.) Rapaics. It is currently being investigated in preclinical research for its neuroprotective potential in cerebral ischemic stroke (CIS). The extract, which contains active C-20 and C-19 diterpenoid alkaloids, has demonstrated the ability to reduce infarct size, improve neurological function, and suppress neuronal apoptosis in animal models such as rats and gerbils. Its mechanism of action is multi-faceted, involving the inhibition of autophagy via the regulation of the AMPK/mTOR/ULK1 signaling pathway and the promotion of cell survival through the PI3K/Akt pathway. Additionally, it exerts antioxidant effects by modulating the KEAP1/NRF2 pathway, thereby reducing oxidative stress and inflammatory markers associated with ischemic injury.

Other names
Aconitum coreanumAconitum coreanum (Lévl.) RapaicsKorean monkshoodGuan Bai Fu
02

Targets

NFE2L2 (Nuclear factor (erythroid-derived 2)-like 2)AKT (RAC-alpha serine/threonine-protein kinase)PI3K (Phosphoinositide-3-kinase regulatory subunit 6)KEAP1 (Kelch-like ECH-associated protein 1)

Beyond the preview

Go deeper on aconitum coreanum extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on aconitum coreanum extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call